000 | 01969 a2200541 4500 | ||
---|---|---|---|
005 | 20250516121201.0 | ||
264 | 0 | _c20130618 | |
008 | 201306s 0 0 eng d | ||
022 | _a1557-3265 | ||
024 | 7 |
_a10.1158/1078-0432.CCR-12-0289 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBahce, Idris | |
245 | 0 | 0 |
_aDevelopment of [(11)C]erlotinib positron emission tomography for in vivo evaluation of EGF receptor mutational status. _h[electronic resource] |
260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cJan 2013 |
||
300 |
_a183-93 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCarbon Radioisotopes _xchemistry |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdiagnostic imaging |
650 | 0 | 4 |
_aErbB Receptors _xgenetics |
650 | 0 | 4 | _aErlotinib Hydrochloride |
650 | 0 | 4 | _aExons |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLung Neoplasms _xdiagnostic imaging |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultimodal Imaging _xmethods |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 | _aPositron-Emission Tomography |
650 | 0 | 4 |
_aQuinazolines _xchemistry |
650 | 0 | 4 | _aTomography, X-Ray Computed |
700 | 1 | _aSmit, Egbert F | |
700 | 1 | _aLubberink, Mark | |
700 | 1 | _avan der Veldt, Astrid A M | |
700 | 1 | _aYaqub, Maqsood | |
700 | 1 | _aWindhorst, Albert D | |
700 | 1 | _aSchuit, Robert C | |
700 | 1 | _aThunnissen, Erik | |
700 | 1 | _aHeideman, Daniƫlle A M | |
700 | 1 | _aPostmus, Pieter E | |
700 | 1 | _aLammertsma, Adriaan A | |
700 | 1 | _aHendrikse, N Harry | |
773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 19 _gno. 1 _gp. 183-93 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-12-0289 _zAvailable from publisher's website |
999 |
_c22248921 _d22248921 |